ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 290 filers reported holding ALKERMES PLC in Q4 2015. The put-call ratio across all filers is 0.77 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $280,744 | +15.6% | 10,023 | +29.2% | 0.00% | – |
Q2 2023 | $242,795 | +7993.2% | 7,757 | +7657.0% | 0.00% | – |
Q1 2022 | $3,000 | -98.8% | 100 | -99.3% | 0.00% | -100.0% |
Q1 2021 | $257,000 | -9.8% | 13,784 | -3.5% | 0.00% | 0.0% |
Q4 2020 | $285,000 | +2.5% | 14,284 | -14.9% | 0.00% | 0.0% |
Q3 2020 | $278,000 | -14.7% | 16,784 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $326,000 | +34.7% | 16,784 | -0.1% | 0.00% | 0.0% |
Q1 2020 | $242,000 | -37.3% | 16,804 | -11.2% | 0.00% | 0.0% |
Q4 2019 | $386,000 | +6.9% | 18,916 | +2.2% | 0.00% | 0.0% |
Q3 2019 | $361,000 | -13.4% | 18,507 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $417,000 | -38.3% | 18,507 | -0.1% | 0.00% | -50.0% |
Q1 2019 | $676,000 | +20.9% | 18,522 | -2.1% | 0.00% | 0.0% |
Q4 2018 | $559,000 | -30.3% | 18,927 | +0.1% | 0.00% | -33.3% |
Q3 2018 | $802,000 | +2.4% | 18,902 | -0.6% | 0.00% | 0.0% |
Q2 2018 | $783,000 | -26.3% | 19,020 | +3.7% | 0.00% | -25.0% |
Q1 2018 | $1,063,000 | +7.0% | 18,339 | +1.1% | 0.00% | 0.0% |
Q4 2017 | $993,000 | +9.2% | 18,141 | +1.5% | 0.00% | 0.0% |
Q3 2017 | $909,000 | -16.9% | 17,877 | -5.3% | 0.00% | -33.3% |
Q2 2017 | $1,094,000 | +3.8% | 18,877 | +4.8% | 0.01% | 0.0% |
Q1 2017 | $1,054,000 | +22.3% | 18,012 | +16.2% | 0.01% | +20.0% |
Q4 2016 | $862,000 | +23.5% | 15,502 | +4.5% | 0.01% | +25.0% |
Q3 2016 | $698,000 | +5.3% | 14,834 | -3.3% | 0.00% | -20.0% |
Q2 2016 | $663,000 | +31.8% | 15,334 | +3.5% | 0.01% | +25.0% |
Q1 2016 | $503,000 | -56.2% | 14,810 | +2.4% | 0.00% | -55.6% |
Q4 2015 | $1,148,000 | +40.2% | 14,460 | +3.6% | 0.01% | +28.6% |
Q3 2015 | $819,000 | -8.8% | 13,960 | 0.0% | 0.01% | -12.5% |
Q2 2015 | $898,000 | +5.5% | 13,960 | 0.0% | 0.01% | 0.0% |
Q1 2015 | $851,000 | -2.2% | 13,960 | -6.1% | 0.01% | -11.1% |
Q4 2014 | $870,000 | +40.5% | 14,860 | -9.2% | 0.01% | +28.6% |
Q3 2014 | $619,000 | -8.6% | 16,360 | +21.5% | 0.01% | -22.2% |
Q2 2014 | $677,000 | +14.2% | 13,460 | 0.0% | 0.01% | 0.0% |
Q1 2014 | $593,000 | +6.5% | 13,460 | -1.8% | 0.01% | -10.0% |
Q4 2013 | $557,000 | +20.8% | 13,710 | 0.0% | 0.01% | +11.1% |
Q3 2013 | $461,000 | +19.4% | 13,710 | +1.9% | 0.01% | 0.0% |
Q2 2013 | $386,000 | – | 13,460 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |